The endocrine system is one of the most underweighted contributors to psychiatric symptoms in standard clinical training. The hypothalamic-pituitary-adrenal (HPA) axis modulates stress response, mood, and cognition through cortisol. The hypothalamic-pituitary-thyroid (HPT) axis affects energy, mood, cognition, and metabolic function through thyroid hormones. The hypothalamic-pituitary-gonadal (HPG) axis influences mood, anxiety, sleep, and cognitive function through reproductive hormones. Each axis interacts with the others; dysfunction in one frequently manifests as psychiatric symptoms attributed to primary psychiatric causes.
The HPA axis is the most familiar but still underutilized clinically. Chronic stress drives HPA dysregulation; the dysregulation drives depression risk, anxiety, sleep disruption, and cognitive symptoms. Cortisol elevation produces hippocampal effects (Stage 19.7); the chronic burden contributes to cognitive aging. Clinically, the workup includes attention to chronic stress exposure, sleep, alcohol patterns, and broader lifestyle factors that drive HPA function. Direct cortisol measurement (salivary, 24-hour urine) is selective use.
The HPT axis is critically important and often inadequately assessed. Subclinical hypothyroidism (TSH 4.0–10.0 with normal free T4) is associated with depression and treatment resistance; T3 augmentation in TRD has substantial evidence (Stage 19.5). Hashimoto's thyroiditis can produce neuropsychiatric symptoms beyond what TSH alone reveals. Free T3, thyroid antibodies, and reverse T3 add depth to the standard TSH workup in selected cases. The HPT axis warrants thoughtful evaluation in psychiatric workup.
The HPG axis modulates psychiatric symptoms throughout the lifespan. Perimenopausal hormonal transitions contribute to depression and anxiety vulnerability windows (Stage 19.2). Premenstrual dysphoric disorder reflects HPG cyclical effects. Hypogonadism in men can produce depression-like symptoms. Postpartum hormonal changes drive postpartum mood disorders. Testosterone and estrogen effects on cognition extend across the lifespan (Stage 19.6). The HPG axis is part of psychiatric assessment in patients where reproductive hormonal context is clinically relevant.
The integrated endocrine-psychiatric approach. The workup includes selective evaluation of the relevant axes based on clinical picture. Treatment integrates hormonal interventions with psychiatric pharmacology and psychotherapy. Lifestyle interventions (sleep, exercise, stress management, dietary attention) affect all three axes. The longevity-psychiatry frame engages endocrine health as part of broader cognitive and psychiatric trajectory; the patient with optimized endocrine function has better mental health outcomes than the patient with subtly dysregulated axes not engaged clinically. The discipline is to recognize endocrine contributions to psychiatric symptoms, conduct appropriate workup, coordinate with primary care or endocrinology when needed, and integrate hormonal optimization into the broader treatment plan.